Dosage & Administration Drug label Prior authorization Pharmacy Financial assistance

Asparlas

(calaspargase pegol)

ASPARLAS 3,750 UNT in 5 mL Injection

NO BLACK BOX WARNING

Dosage & administration

* Recommended Dosage: 2,500 units/m2 intravenously no more frequently than every 21 days.
* See Full Prescribing Information for important details regarding dosing modifications and preparation and administration.

drug label

Asparlas prescribing information

Contact Medical Science Liaison Report Adverse Event

prior authorization

Asparlas prior authorization resources

Most recent Asparlas prior authorization forms

View By Payer

Verified: Sep 27, 2023Cigna - Asparlas Prior Authorization Form

Learn More

pharmacy

Asparlas preferred pharmacy

PDFPharmacy List

financial assistance

Asparlas financial assistance options

Co-pay savings program

commercial only

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Foundation programs

under insured

no insurance

goverment insurance

65+

OTHERAsparlas Patient Assistance Program

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.

How to sign up

Patients submit proof of out-of-pocket drug costs to charities for reimbursement

patient education

Asparlas patient education

Getting started on Asparlas

To share resource; ask patient to:

1.Pull out phone

2.Open camera

3.Scan QR code with camera

4.Tap link